Livagen® 20mg
CAS: 195875-84-4 (Deprecated: 402856-42-2)
Livagen 20mg by BioPeptides is a high-purity, research-grade liver bioregulatory peptide developed for advanced laboratory studies in hepatic cellular signaling, gene expression regulation, and tissue-specific peptide research. Synthesized using precision peptide technology and purified to ≥99% HPLC, Livagen delivers consistent molecular accuracy and reproducibility. Identified by CAS 195875-84-4, this peptide is widely used in controlled in-vitro research models across Europe and the United States. BioPeptides provides secure access to premium research peptides with verified documentation and professional laboratory packaging.
$145.00
Research Use Only
Research Overview
Livagen is a synthetic peptide classified as a liver-specific regulatory peptide studied in cellular signaling research.
Researchers investigate Livagen for its role in modulating gene expression and peptide-mediated signaling pathways within hepatic cells.
The peptide is often used in laboratory models exploring liver tissue regulation and intracellular communication mechanisms.
The 20mg research format supports extended experiments and multiple biochemical assays.
Scientific Background
Organ-specific regulatory peptides are studied for their role in controlling cellular signaling and gene transcription.
Livagen belongs to a group of peptides investigated for their interaction with hepatic tissue pathways.
In research environments, these peptides are used to examine mechanisms of cellular differentiation, tissue regeneration, and gene regulation.
Because of its targeted nature, Livagen is frequently studied in hepatic cell culture models.
Mechanistic Research Perspective
- Hepatic gene expression modulation research
- Liver tissue cellular signaling studies
- Peptide-mediated transcription regulation
- Organ-specific bioregulator pathway analysis
- Intracellular communication and differentiation research
Primary Research Applications
Hepatic Cellular Regulation Studies: Livagen is used to investigate regulatory signaling mechanisms within liver-derived cell models.
Gene Expression & Epigenetic Research: Researchers study Livagen to explore transcriptional modulation and epigenetic regulatory processes in hepatic systems.
Tissue-Specific Peptide Research: Livagen enables studies focused on organ-targeted peptide signaling and cellular regulation.
Cellular & Molecular Biology Research: Laboratories incorporate Livagen into cell-based assays examining intracellular communication and signaling responses.
In-Vitro Research Models: Livagen is widely used in non-clinical in-vitro research studying liver biology and peptide signaling behavior.
Molecular Characteristics
- Compound Name: Livagen®
- CAS Number: 195875-84-4
- Peptide Class: Liver-specific regulatory peptide
- Form: Lyophilized peptide powder
- Purity: ≥99% HPLC verified
- Unit Size: 20mg research format
Stability Profile and Storage Recommendations
- Store lyophilized peptide at −20°C
- Protect from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions should be refrigerated
- Use sterile laboratory solvents during preparation
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solutions
- Buffered aqueous laboratory solutions
- Biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
Livagen® 20mg
brand
BioPeptides
cas
195875-84-4
purity
≥99% (HPLC verified)
unit Size
20mg vial
form
Lyophilized powder
synthesis
Peptide synthesis technology
analytical
HPLC and Mass Spectrometry
molecular Structure
Short liver bioregulator peptide
stability
Stable when stored at −20°C
Analytical Validation and Quality Assurance
- High-performance liquid chromatography purity verification
- Mass spectrometry molecular weight confirmation
- Peptide structural integrity validation
- Batch-to-batch analytical consistency testing
- Peptide stability verification
Regulatory and Compliance Statement
Livagen supplied by BioPeptides is intended strictly for laboratory and scientific research use only. It is not approved for human consumption, veterinary use, cosmetic applications, or therapeutic treatments.
Frequently Asked Questions
Livagen is primarily studied for liver-specific cellular regulation, gene expression modulation, and peptide-mediated signaling within hepatic research models.
Livagen is designed as an organ-specific regulatory peptide studied primarily for its effects within liver-derived cellular systems.
CAS 195875-84-4 uniquely identifies Livagen, ensuring accurate compound identification and reproducibility across laboratory documentation.
Yes. Livagen is commonly used in hepatic cell culture models and biochemical assays investigating cellular signaling pathways.
Livagen is used in liver biology, molecular biology, peptide signaling research, and epigenetic gene regulation studies.
The 20mg format allows extended research programs and multiple assays without frequent reordering.
Lyophilized Livagen should be stored at −20°C and protected from moisture and light.
BioPeptides provides high-purity research peptides with verified CAS documentation and reliable shipping for laboratories.